Richard Whitley to Neoplasms
This is a "connection" page, showing publications Richard Whitley has written about Neoplasms.
Connection Strength
0.103
-
Varicella-zoster virus infections: chronic disease in the immunocompromised host: evidence for persistent excretion of virus. Pediatr Infect Dis J. 1989 Sep; 8(9):584-5.
Score: 0.031
-
Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12. Cancer Gene Ther. 2005 Apr; 12(4):359-68.
Score: 0.023
-
Management of infections. Pediatr Ann. 1983 Jun; 12(6):445-9.
Score: 0.020
-
Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications. Clin Microbiol Infect. 2002 Sep; 8(9):551-63.
Score: 0.019
-
Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host. J Infect Dis. 1984 Jan; 149(1):1-8.
Score: 0.005
-
Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27; 294(22):1193-9.
Score: 0.003
-
Acyclovir kinetics after intravenous infusion. Clin Pharmacol Ther. 1979 Dec; 26(6):718-28.
Score: 0.001
-
Serum antibody levels as risk factors in the dissemination of herpes zoster. Arch Intern Med. 1979 Dec; 139(12):1341-5.
Score: 0.001
-
Adenine arabinoside for therapy of herpes zoster in immunosuppressed patients: preliminary results of a collaborative study. J Infect Dis. 1976 Jun; 133 Suppl:A184-91.
Score: 0.001